Status: Recruiting
FebriDx® Pediatric Validation Study
The primary objective of this study is to determine performance characteristics of the FebriDx® test in differentiating bacterial from non-bacterial etiology among febrile pediatric patients (2-11 years) presenting to the emergency department, urgent care center or primary care office with a suspected acute respiratory tract infection.
Participants needed: 800
Trial details
Age: 2-11Biological sex: AllType: ObservationalSponsor: Lumos DiagnosticsUpdated: Oct 31, 2025Locations: 10
Eligibility criteria
Signed informed consent by parent/guardian and Assent for ages 7-11 years [+2]
Unwilling to participate in 7-day follow-up or sign HIPAA waiver to obtain medic... [+5]